Pfizer, the world's biggest drug maker, said Tuesday it was terminating development of two medicines aimed at treating pain and anxiety disorders to focus on higher-potential development programs.
It would halt "phase 3 development programs" for investigational compounds for fibromyalgia and for generalized anxiety disorder, the company said in a statement.
Fibromyalgia - Causes, Symptoms, Diagnosis, Treatment & Support Groups
Fibromyalgia (FM) is a chronic health condition charecterized by widespread pain and stiffness in the muscles, joints and tendons. It is considered to be a co-morbid disorder.
Fibromyalgia (FM) is a chronic health condition charecterized by widespread pain and stiffness in the muscles, joints and tendons. It is considered to be a co-morbid disorder.
The decision to terminate the two programs will enable the business unit "to allocate additional resources to higher-potential development programs as part of its continuing effort to deliver greater value to patients and Pfizer shareholders," the company said in a statement.
Pfizer said it would push ahead for approval for using its Lyrica drug to treat generalized anxiety disorder, a chronic condition with symptoms including persistent anxiety, exaggerated worry and tension.
Anxiety Disorder - Types - Causes - Symptoms - Diagnosis - Treatment - FAQs
Anxiety disorder involves excessive worry about actual circumstances, events or conflicts. Anyone can develop this disorder. Genes may play a role.
Anxiety disorder involves excessive worry about actual circumstances, events or conflicts. Anyone can develop this disorder. Genes may play a role.
In June 2007, Lyrica became the first FDA-approved treatment for the management of fibromyalgia, and Pfizer said it continued to support research and education in this complex pain condition.
Advertisement
Anxiety Screening Test
Are you anxious to know your anxiety level? Use Medindia’s Anxiety Screening Test, a simple online screening test for anxiety symptoms.
Are you anxious to know your anxiety level? Use Medindia’s Anxiety Screening Test, a simple online screening test for anxiety symptoms.
Source-AFP
SRM
Fibromyalgia Occurs More in Women Than Men
Women are more likely to suffer from fibromyalgia, a chronic condition that causes exhaustion, sleep disturbances and diffuse pain in your muscles, tendons, and ligaments, than men, say experts.
Women are more likely to suffer from fibromyalgia, a chronic condition that causes exhaustion, sleep disturbances and diffuse pain in your muscles, tendons, and ligaments, than men, say experts.
